Janice Jarrett
Optometrist · Denver, CONPI 1811978869
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,156 of the $21,678 with a category attached, or 97.6%. Optos, Inc. accounts for 97.6% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $21,357, more than ten times the $53 reported in 2019. Among optometrist clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 10 payments — averaging $2167.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optos, Inc.$21K
- Maculogix, Inc.$158
- Ocular Therapeutix, Inc.$150
- Coopervision Inc.$58
- Astellas Pharma US Inc$34
- Visioneering Technologies, Inc.$30
- plus $92 from 4 others
What the payments were for
- Speaking & faculty fees$21,15698%
- Food & beverage$5042%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optos, Inc. | 1 | $21,156 |
| Maculogix, Inc. | 1 | $158 |
| Ocular Therapeutix, Inc. | 1 | $150 |
| Coopervision Inc. | 1 | $58 |
| Astellas Pharma US Inc | 1 | $34 |
| Visioneering Technologies, Inc. | 1 | $30 |
| ABB Con-cise Optical Group LLC | 1 | $28 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $23 |
| Bausch & Lomb Americas Inc. | 1 | $23 |
| Carl Zeiss Meditec AG | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AdaptDx$158
How this compares
$21,678 in reported general payments places this provider in the 95th percentile of 1,025 optometrist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate | 43 | $2,971 |
| Latanoprost | 75 | $965 |
| Timolol Maleate | 21 | $80 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Denver
- Betty ZhangDenver$29K
- Tammy GrayDenver$8K
- Rachel LewisDenver$8K
- Richard WinnickDenver$6K
- Kenneth PhiDenver$6K
- Curt GreeleyDenver$5K
- Alexia BounkhongDenver$5K
- Benjamin WartaDenver$5K
- Cecelia KoettingAurora$458K
- Kaleb AbbottAurora$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.